Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
32,315,113
-
Total 13F shares
-
1,825,442
-
Share change
-
-1,334,050
-
Total reported value
-
$8,178,246
-
Put/Call ratio
-
123%
-
Price per share
-
$4.48
-
Number of holders
-
30
-
Value change
-
-$6,187,980
-
Number of buys
-
8
-
Number of sells
-
30
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2018
As of 30 Jun 2018,
XBiotech Inc. - Common Shares, no par value (XBIT) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,825,442 shares.
The largest 10 holders included
VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Paloma Partners Management Co, BlackRock Inc., ELEMENT CAPITAL MANAGEMENT LLC, SCHWAB CHARLES INVESTMENT MANAGEMENT INC, CREDIT SUISSE AG/, NORTHERN TRUST CORP, and DIMENSIONAL FUND ADVISORS LP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.